INCY vs. CAH
INCY (Incyte Corporation) and CAH (Cardinal Health, Inc.) are both stocks. Both are in the Healthcare sector — INCY in Biotechnology, CAH in Medical Distribution. Over the past 10 years, INCY returned 3.13%/yr vs 14.31%/yr for CAH. At a 0.24 correlation, their price movements are largely independent.
Performance
INCY vs. CAH - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with INCY having a 9.88% return and CAH slightly lower at 9.47%. Over the past 10 years, INCY has underperformed CAH with an annualized return of 3.13%, while CAH has yielded a comparatively higher 14.31% annualized return.
INCY
- 1D
- 0.65%
- 1M
- 9.83%
- YTD
- 9.88%
- 6M
- 13.75%
- 1Y
- 56.79%
- 3Y*
- 20.55%
- 5Y*
- 5.62%
- 10Y*
- 3.13%
CAH
- 1D
- 1.22%
- 1M
- 20.12%
- YTD
- 9.47%
- 6M
- 13.51%
- 1Y
- 41.03%
- 3Y*
- 38.77%
- 5Y*
- 33.47%
- 10Y*
- 14.31%
INCY vs. CAH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
INCY Incyte Corporation | 9.88% | 43.00% | 10.00% | -21.83% | 9.43% | -15.61% | -0.39% | 37.32% | -32.86% | -5.55% |
CAH Cardinal Health, Inc. | 9.47% | 76.25% | 19.01% | 34.15% | 54.08% | -0.40% | 10.09% | 18.04% | -24.50% | -12.65% |
Correlation
The correlation between INCY and CAH is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Nov 4, 1993 | 0.24 |
Fundamentals
INCY:
$22.45B
CAH:
$52.83B
INCY:
$7.06
CAH:
$6.55
INCY:
15.38
CAH:
34.17
INCY:
0.02
CAH:
0.81
INCY:
4.11
CAH:
0.21
INCY:
$5.36B
CAH:
$250.55B
INCY:
$3.76B
CAH:
$9.23B
INCY:
$1.80B
CAH:
$2.79B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INCY vs. CAH — Risk / Return Rank
INCY
CAH
INCY vs. CAH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Incyte Corporation (INCY) and Cardinal Health, Inc. (CAH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| INCY | CAH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.35 | ||
| Sortino ratioReturn per unit of downside risk | +0.26 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.30 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 3.11 | 2.02 | +1.09 |
| Martin ratioReturn relative to average drawdown | 6.94 | 5.31 | +1.63 |
Loading charts...
Drawdowns
INCY vs. CAH - Drawdown Comparison
The maximum INCY drawdown since its inception was -98.54%, which is greater than CAH's maximum drawdown of -61.93%. Use the drawdown chart below to compare losses from any high point for INCY and CAH.
Loading charts...
Drawdown Indicators
| INCY | CAH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.54% | -61.93% | -36.61% |
Max Drawdown (1Y)Largest decline over 1 year | -18.33% | -20.42% | +2.09% |
Max Drawdown (3Y)Largest decline over 3 years | -33.83% | -20.42% | -13.41% |
Max Drawdown (5Y)Largest decline over 5 years | -41.06% | -22.80% | -18.26% |
Max Drawdown (10Y)Largest decline over 10 years | -66.47% | -46.13% | -20.34% |
Current DrawdownCurrent decline from peak | -28.91% | -2.39% | -26.52% |
Average DrawdownAverage peak-to-trough decline | -59.88% | -15.94% | -43.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.21% | 7.75% | +0.46% |
Volatility
INCY vs. CAH - Volatility Comparison
Incyte Corporation (INCY) has a higher volatility of 9.64% compared to Cardinal Health, Inc. (CAH) at 7.19%. This indicates that INCY's price experiences larger fluctuations and is considered to be riskier than CAH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INCY | CAH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.64% | 7.19% | +2.45% |
Volatility (6M)Calculated over the trailing 6-month period | 22.73% | 20.32% | +2.41% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.10% | 30.30% | +2.80% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.32% | 25.24% | +4.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.29% | 29.26% | +5.03% |
Dividends
INCY vs. CAH - Dividend Comparison
INCY has not paid dividends to shareholders, while CAH's dividend yield for the trailing twelve months is around 0.91%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CAH Cardinal Health, Inc. | 0.91% | 0.99% | 1.28% | 1.98% | 2.57% | 3.80% | 3.62% | 3.80% | 4.24% | 3.00% | 2.41% | 1.68% |
INCY Incyte Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
INCY vs. CAH - Financials Comparison
This section allows you to compare key financial metrics between Incyte Corporation and Cardinal Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
INCY vs. CAH - Profitability Comparison
INCY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Incyte Corporation reported a gross profit of 0.00 and revenue of 1.27B. Therefore, the gross margin over that period was 0.0%.
CAH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cardinal Health, Inc. reported a gross profit of 2.50B and revenue of 60.94B. Therefore, the gross margin over that period was 4.1%.
INCY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Incyte Corporation reported an operating income of 301.12M and revenue of 1.27B, resulting in an operating margin of 23.7%.
CAH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cardinal Health, Inc. reported an operating income of 509.00M and revenue of 60.94B, resulting in an operating margin of 0.8%.
INCY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Incyte Corporation reported a net income of 303.33M and revenue of 1.27B, resulting in a net margin of 23.8%.
CAH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cardinal Health, Inc. reported a net income of 399.00M and revenue of 60.94B, resulting in a net margin of 0.7%.
Frequently Asked Questions
INCY and CAH have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
INCY has higher volatility (9.64%) compared to CAH (7.19%). In terms of maximum drawdown, INCY dropped -98.54% vs CAH's -61.93%.
INCY currently has the higher Sharpe Ratio (1.72 vs 1.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INCY and CAH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer